2019 Great Debates and Updates in GI Malignancies Recap with Axel Grothey, MD

Posted by & filed under News.

​At Great Debates and Updates in GI Malignancies, nationally recognized thought leaders take opposing sides on clinical, and sometimes controversial, topics currently disrupting the practice of gastrointestinal oncology. Through comprehensive review of the latest clinical advancements in gastrointestinal malignancies, robust audience engagement, and ample discussion, participants will leave equipped with practical implications and applications to… Read more »

5th Annual West Oncology Conference

Posted by & filed under Events, News.

5th Annual West Oncology Conference Dates: Friday + Saturday, February 28 + 29, 2020 Location: THE GUEST HOUSE AT GRACELAND 3600 Elvis Presley Boulevard Memphis, TN 38116   This meeting will serve as a valuable forum for the presentation and discussion of new research findings. Participants will be provided with an update on practice-changing data… Read more »

Dr. Matthew Ballo and Dr. Yuefang Wang attend CSTRO (Chinese Society of Therapeutic Radiation Oncology)

Posted by & filed under News.

West Cancer Center’s reputation is spreading internationally as a leader in cancer treatments, especially in the management of solid malignancies with Tumor Treating Fields, with the most clinical experience from a single institute. West’s Radiation Oncology Department was honored to be represented by Drs. Matthew Ballo and Yuefeng Wang who spoke at the 2019 CSTRO… Read more »

Margaret West Comprehensive Breast Center: Exceeding the standards for superior breast screening and diagnostic services

Posted by & filed under News.

Margaret West Comprehensive Breast Center: Exceeding the standards for superior breast screening and diagnostic services   Dr. Landrieu has joined Dr. Patricia Turner, Director of Breast Imaging, at the Margaret West Comprehensive Breast Center this month. Having worked together for over 17 years in high volume breast practices, they have collectively interpreted over 1 million breast… Read more »

West is 1 of 10 for ASCO Conquer Cancer Foundation Grant

Posted by & filed under News.

West Cancer Center & Research Institute (WCCRI) was selected as 1 of 10 oncology practices in the country to receive a grant from ASCO’s Conquer Cancer Foundation to serve medically underserved populations in our community. West Cancer Center is committed to closing the gap in cancer care disparity in the Mid-South. Since 1979, West has spent over… Read more »

Survival After Robotic-Assisted Prostatectomy for Localized Prostate Cancer: An Epidemiologic Study.

Posted by & filed under News.

  Click here to read the full story. Survival After Robotic-Assisted Prostatectomy for Localized Prostate Cancer: An Epidemiologic Study. November 5, 2019 To determine the potential survival benefit associated with robotic-assisted laparoscopic prostatectomy (RALP) compared to open radical prostatectomy (ORP) for prostate cancer.   RALP has become the dominant surgical approach for localized disease in… Read more »

Dr. Martin in Nepal

Posted by & filed under News.

West Cancer Center’s Medical Oncologist, Dr. Michael Martin – living our mission to help cancer patients everywhere. Dr. Martin joined the American Society of Clinical Oncology (ASCO) and  Health Volunteer Overseas (HVO) in Kathmandu, Nepal to bring new oncology technologies and treatments to physicians and provide hope for patients battling cancer. Our providers at West take… Read more »

West is 1st center in the country to offer the 1st FDA-approved Mesothelioma treatment in more than 15 years

Posted by & filed under News.

West Cancer Center is the first center in the country to offer the first FDA-approved Mesothelioma treatment in more than 15 years A clinical study showed that the NovoTTF-100L™ System in combination with chemotherapy may help people with malignant pleural mesothelioma extend their lives   West Cancer Center is pleased to announce they have been… Read more »

Common Treatment-Related Toxicities in mRCC

Posted by & filed under News.

Heather Greene, a nurse practitioner at West Cancer Center, discusses common treatment-related toxicities in metastatic renal cell carcinoma (RCC). In terms of anti-VEGF tyrosine kinase inhibitors (TKIs), healthcare providers should be aware of potential diarrhea, hypertension, palmar-plantar erythrodysesthesia, as well as skin and hair depigmentation, says Greene. Patients who are receiving mTOR inhibitors should be… Read more »

Dr. Somer on Immunotherapy Combinations in mRCC

Posted by & filed under News.

Bradley G. Somer, MD, associate professor of hematology/oncology, head of strategic expansion/development, University of Tennessee West Cancer Center, discusses the potential for immunotherapy combinations in patients with Metastatic Renal Cell Carcinoma (mRCC). In the CheckMate-214 study, the combination of Nivolumab (Opdivo) and Ipilimumab (Yervoy) showed a clear survival advantage over the frontline standard-of-care Sunitinib (Sutent)… Read more »

X